Neutralizing Anti-Heat-Stable Toxin (STa) Antibodies Derived from Enterotoxigenic Escherichia coli Toxoid Fusions with STa Proteins Containing N12S, L9A/N12S, or N12S/A14T Mutations Show Little Cross-Reactivity with Guanylin or Uroguanylin
- 15 January 2018
- journal article
- research article
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 84 (2)
- https://doi.org/10.1128/aem.01737-17
Abstract
Heat-stable toxin (STa)-producing enterotoxigenic Escherichia coli (ETEC) strains are a top cause of moderate-to-severe diarrhea in children from developing countries and a common cause of travelers' diarrhea. Recent progress in using STa toxoids and toxoid fusions to induce neutralizing anti-STa antibodies accelerates ETEC vaccine development. However, concern remains whether the derived anti-STa antibodies cross-react with STa-like guanylin and uroguanylin, two GC-C ligands regulating the fluid and electrolyte transportation in human intestinal and renal epithelial cells. To further divert STa from guanylin and uroguanylin structurally and antigenically and to eliminate anti-STa antibody cross-reactivity with guanylin and uroguanylin, we mutated STa toxin at the 9th (leucine), the 12th (asparagine) and the 14th (alanine) residues for double and triple mutants STaL9A/N12S, STaL9A/A14H, STaN12S/A14T and STaL9A/N12S/A14H. We then fused each STa mutant (three copies) to a monomeric LT mutant (mnLTR192G/L211A) for toxoid fusions 3xSTaL9A/N12S-mnLTR192G/L211A, 3xSTaL9A/A14H-mnLTR192G/L211A, 3xSTaN12S/A14T-mnLTR192G/L211A and 3xSTaL9A/N12S/A14H-mnLTR192G/L211A, examined each fusion for anti-STa immunogenicity, and assessed derived antibodies for in vitro neutralization activity against STa toxicity and for cross-reactivity with guanylin and uroguanylin. Mice subcutaneously immunized with each fusion protein developed anti-STa antibodies, and the antibodies derived from 3xSTaN12S-mnLTR192G/L211A, 3xSTaL9A/N12S-mnLTR192G/L211A or 3xSTaN12S/A14T-mnLTR192G/L211A prevented STa from stimulation of intracellular cGMP in T-84 cells. Competitive ELISAs showed guanylin and uroguanylin hardly blocked the binding of anti-STa antibodies to the coated STa-ovalbumin conjugate. These results indicated that the antibodies derived from 3xSTaN12S-mnLTR192G/L211A, 3xSTaL9A/N12S-mnLTR192G/L211A or 3xSTaN12S/A14T-mnLTR192G/L211A neutralized STa toxin and had little cross-reactivity with guanylin and uroguanylin, suggesting these toxoid fusions are suitable antigens for ETEC vaccines.Keywords
Funding Information
- National Institute of Health (R01AI121067)
- PATH
This publication has 25 references indexed in Scilit:
- Etiology of travellers’ diarrheaJournal of Travel Medicine, 2017
- An assessment of enterotoxigenic Escherichia coli and Shigella vaccine candidates for infants and childrenVaccine, 2015
- Characterization of Heat-Stable (STa) Toxoids of Enterotoxigenic Escherichia coli Fused to Double Mutant Heat-Labile Toxin Peptide in Inducing Neutralizing Anti-STa AntibodiesInfection and Immunity, 2014
- Toxicity and Immunogenicity of Enterotoxigenic Escherichia coli Heat-Labile and Heat-Stable Toxoid Fusion 3xSTaA14Q-LTS63K/R192G/L211A in a Murine ModelPLOS ONE, 2013
- The Global Enteric Multicenter Study (GEMS) of Diarrheal Disease in Infants and Young Children in Developing Countries: Epidemiologic and Clinical Methods of the Case/Control StudyClinical Infectious Diseases, 2012
- Progress and hurdles in the development of vaccines against enterotoxigenicEscherichia coliin humansExpert Review of Vaccines, 2012
- Heat-Labile- and Heat-Stable-Toxoid Fusions (LT R192G -STa P13F ) of Human Enterotoxigenic Escherichia coli Elicit Neutralizing Antitoxin AntibodiesInfection and Immunity, 2011
- Travelersʼ diarrheaCurrent Opinion in Infectious Diseases, 2010
- Genetic Fusions of Heat-Labile (LT) and Heat-Stable (ST) Toxoids of Porcine EnterotoxigenicEscherichia coliElicit Neutralizing Anti-LT and Anti-STa antibodiesInfection and Immunity, 2010
- Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and MexicoVaccine, 2007